Concepts (174)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| HIV Infections | 41 | 2026 | 2037 | 6.070 |
Why?
|
| Infectious Disease Transmission, Vertical | 13 | 2025 | 261 | 3.190 |
Why?
|
| Anti-HIV Agents | 14 | 2025 | 353 | 3.070 |
Why?
|
| Malawi | 33 | 2026 | 338 | 2.980 |
Why?
|
| Pregnancy Complications, Infectious | 12 | 2025 | 499 | 2.560 |
Why?
|
| Anti-Retroviral Agents | 10 | 2018 | 154 | 2.170 |
Why?
|
| Counseling | 6 | 2023 | 237 | 1.940 |
Why?
|
| Health Personnel | 9 | 2025 | 549 | 1.600 |
Why?
|
| Mass Screening | 7 | 2026 | 814 | 1.260 |
Why?
|
| Medication Adherence | 5 | 2023 | 335 | 1.240 |
Why?
|
| Burnout, Professional | 2 | 2019 | 133 | 0.990 |
Why?
|
| Community Health Workers | 8 | 2026 | 80 | 0.930 |
Why?
|
| Pregnancy | 21 | 2025 | 7407 | 0.840 |
Why?
|
| Quality of Health Care | 2 | 2018 | 409 | 0.810 |
Why?
|
| Child Health Services | 3 | 2018 | 86 | 0.700 |
Why?
|
| Intimate Partner Violence | 1 | 2021 | 30 | 0.690 |
Why?
|
| Depression | 4 | 2022 | 1317 | 0.650 |
Why?
|
| Community Health Services | 2 | 2021 | 87 | 0.650 |
Why?
|
| Audiovisual Aids | 1 | 2020 | 22 | 0.620 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2026 | 500 | 0.580 |
Why?
|
| Viral Load | 4 | 2025 | 406 | 0.570 |
Why?
|
| Syphilis | 1 | 2019 | 95 | 0.560 |
Why?
|
| Ambulatory Care Facilities | 2 | 2017 | 233 | 0.520 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2018 | 218 | 0.510 |
Why?
|
| Family Characteristics | 1 | 2017 | 97 | 0.500 |
Why?
|
| Female | 36 | 2026 | 70388 | 0.500 |
Why?
|
| Adult | 19 | 2026 | 31179 | 0.480 |
Why?
|
| Self Report | 4 | 2020 | 555 | 0.450 |
Why?
|
| Chemoprevention | 1 | 2015 | 49 | 0.450 |
Why?
|
| Antiretroviral Therapy, Highly Active | 3 | 2016 | 258 | 0.450 |
Why?
|
| Breast Feeding | 5 | 2025 | 233 | 0.430 |
Why?
|
| Mental Disorders | 1 | 2022 | 899 | 0.420 |
Why?
|
| Drug Monitoring | 1 | 2017 | 287 | 0.410 |
Why?
|
| Humans | 42 | 2026 | 130483 | 0.390 |
Why?
|
| Cross-Sectional Studies | 6 | 2022 | 3806 | 0.390 |
Why?
|
| Young Adult | 10 | 2026 | 10010 | 0.340 |
Why?
|
| Infant | 15 | 2026 | 13234 | 0.320 |
Why?
|
| Psychometrics | 1 | 2014 | 671 | 0.320 |
Why?
|
| Treatment Adherence and Compliance | 2 | 2020 | 10 | 0.310 |
Why?
|
| Video Recording | 2 | 2023 | 207 | 0.310 |
Why?
|
| Infant, Newborn | 11 | 2025 | 8518 | 0.310 |
Why?
|
| Malnutrition | 1 | 2012 | 155 | 0.310 |
Why?
|
| AIDS Serodiagnosis | 3 | 2019 | 52 | 0.280 |
Why?
|
| Adolescent | 13 | 2026 | 20737 | 0.280 |
Why?
|
| Male | 21 | 2026 | 64488 | 0.260 |
Why?
|
| Pregnancy Complications | 1 | 2012 | 540 | 0.260 |
Why?
|
| Child, Preschool | 12 | 2026 | 14945 | 0.250 |
Why?
|
| Child | 15 | 2026 | 26101 | 0.240 |
Why?
|
| Tenofovir | 1 | 2025 | 26 | 0.240 |
Why?
|
| Dried Blood Spot Testing | 1 | 2025 | 27 | 0.230 |
Why?
|
| Disclosure | 2 | 2017 | 150 | 0.230 |
Why?
|
| Surveys and Questionnaires | 3 | 2021 | 4021 | 0.220 |
Why?
|
| Adenine | 1 | 2025 | 120 | 0.220 |
Why?
|
| Feasibility Studies | 2 | 2026 | 812 | 0.220 |
Why?
|
| Qualitative Research | 2 | 2025 | 698 | 0.200 |
Why?
|
| Prenatal Care | 2 | 2019 | 346 | 0.200 |
Why?
|
| Psychiatric Status Rating Scales | 2 | 2018 | 832 | 0.200 |
Why?
|
| Pilot Projects | 2 | 2021 | 1448 | 0.200 |
Why?
|
| Lost to Follow-Up | 2 | 2018 | 32 | 0.170 |
Why?
|
| Tuberculosis | 2 | 2017 | 554 | 0.170 |
Why?
|
| Delivery of Health Care, Integrated | 2 | 2013 | 142 | 0.160 |
Why?
|
| Learning | 1 | 2024 | 370 | 0.160 |
Why?
|
| Prevalence | 2 | 2019 | 2699 | 0.160 |
Why?
|
| Logistic Models | 2 | 2017 | 1810 | 0.160 |
Why?
|
| Type D Personality | 1 | 2019 | 3 | 0.160 |
Why?
|
| Marital Status | 1 | 2019 | 33 | 0.150 |
Why?
|
| Multicenter Studies as Topic | 1 | 2020 | 298 | 0.150 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2024 | 1266 | 0.140 |
Why?
|
| Job Satisfaction | 1 | 2019 | 100 | 0.140 |
Why?
|
| CD4 Lymphocyte Count | 3 | 2013 | 231 | 0.140 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2019 | 130 | 0.140 |
Why?
|
| Depersonalization | 1 | 2018 | 10 | 0.140 |
Why?
|
| Africa | 1 | 2018 | 140 | 0.140 |
Why?
|
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2017 | 39 | 0.130 |
Why?
|
| Multivariate Analysis | 2 | 2018 | 1376 | 0.130 |
Why?
|
| Stereotyping | 1 | 2017 | 19 | 0.130 |
Why?
|
| Contact Tracing | 3 | 2024 | 58 | 0.130 |
Why?
|
| Attitude of Health Personnel | 2 | 2025 | 703 | 0.130 |
Why?
|
| Drug Prescriptions | 1 | 2018 | 230 | 0.120 |
Why?
|
| Infection Control | 1 | 2017 | 162 | 0.120 |
Why?
|
| Regression Analysis | 1 | 2018 | 760 | 0.120 |
Why?
|
| Pregnancy Outcome | 1 | 2019 | 615 | 0.120 |
Why?
|
| Program Evaluation | 2 | 2021 | 443 | 0.120 |
Why?
|
| Risk Factors | 4 | 2021 | 10953 | 0.120 |
Why?
|
| Bullying | 1 | 2015 | 17 | 0.120 |
Why?
|
| Sex Factors | 1 | 2019 | 1343 | 0.120 |
Why?
|
| Epidemiologic Methods | 1 | 2015 | 92 | 0.120 |
Why?
|
| Survival Analysis | 1 | 2018 | 1491 | 0.110 |
Why?
|
| Cross Infection | 1 | 2017 | 332 | 0.110 |
Why?
|
| Hearing Loss | 1 | 2016 | 204 | 0.110 |
Why?
|
| Antitubercular Agents | 1 | 2016 | 269 | 0.100 |
Why?
|
| Drug Utilization | 1 | 2015 | 163 | 0.100 |
Why?
|
| Social Work | 1 | 2013 | 21 | 0.100 |
Why?
|
| Public Health | 1 | 2016 | 272 | 0.100 |
Why?
|
| Schools | 1 | 2015 | 236 | 0.100 |
Why?
|
| Premedication | 1 | 2013 | 39 | 0.100 |
Why?
|
| Child Nutrition Disorders | 1 | 2013 | 41 | 0.100 |
Why?
|
| Long-Term Care | 1 | 2013 | 70 | 0.100 |
Why?
|
| ROC Curve | 1 | 2014 | 612 | 0.090 |
Why?
|
| Community Networks | 1 | 2012 | 30 | 0.090 |
Why?
|
| Outpatients | 1 | 2014 | 265 | 0.090 |
Why?
|
| Food, Formulated | 1 | 2012 | 38 | 0.090 |
Why?
|
| Mental Health | 1 | 2015 | 371 | 0.090 |
Why?
|
| Maternal Health Services | 1 | 2011 | 46 | 0.080 |
Why?
|
| Early Diagnosis | 3 | 2018 | 189 | 0.080 |
Why?
|
| Sensitivity and Specificity | 1 | 2014 | 2105 | 0.070 |
Why?
|
| Predictive Value of Tests | 1 | 2014 | 2298 | 0.070 |
Why?
|
| Combined Modality Therapy | 1 | 2012 | 1226 | 0.070 |
Why?
|
| Longitudinal Studies | 1 | 2012 | 1488 | 0.070 |
Why?
|
| Retrospective Studies | 4 | 2016 | 17550 | 0.070 |
Why?
|
| Polymerase Chain Reaction | 1 | 2011 | 1455 | 0.070 |
Why?
|
| Risk Assessment | 4 | 2021 | 3679 | 0.060 |
Why?
|
| Follow-Up Studies | 1 | 2016 | 5176 | 0.060 |
Why?
|
| Organophosphates | 1 | 2025 | 17 | 0.060 |
Why?
|
| Lamivudine | 1 | 2025 | 29 | 0.060 |
Why?
|
| Patient Compliance | 2 | 2021 | 461 | 0.060 |
Why?
|
| Ethics Committees, Research | 1 | 2024 | 29 | 0.050 |
Why?
|
| Postpartum Period | 1 | 2025 | 238 | 0.050 |
Why?
|
| Treatment Outcome | 2 | 2016 | 12843 | 0.050 |
Why?
|
| Interviews as Topic | 1 | 2024 | 444 | 0.050 |
Why?
|
| Capacity Building | 1 | 2021 | 26 | 0.040 |
Why?
|
| Live Birth | 1 | 2021 | 69 | 0.040 |
Why?
|
| Nutritional Status | 2 | 2013 | 300 | 0.040 |
Why?
|
| Mentors | 1 | 2021 | 168 | 0.040 |
Why?
|
| Health Services Accessibility | 2 | 2017 | 694 | 0.040 |
Why?
|
| Drug Compounding | 1 | 2019 | 40 | 0.040 |
Why?
|
| Time Factors | 2 | 2021 | 6200 | 0.040 |
Why?
|
| Sexual Partners | 1 | 2019 | 80 | 0.040 |
Why?
|
| Family Health | 1 | 2019 | 242 | 0.040 |
Why?
|
| Congresses as Topic | 1 | 2019 | 185 | 0.030 |
Why?
|
| Lactation | 1 | 2019 | 197 | 0.030 |
Why?
|
| Health Services Research | 1 | 2018 | 179 | 0.030 |
Why?
|
| Developing Countries | 1 | 2019 | 301 | 0.030 |
Why?
|
| Audiometry, Pure-Tone | 1 | 2016 | 24 | 0.030 |
Why?
|
| Delivery of Health Care | 1 | 2021 | 679 | 0.030 |
Why?
|
| Chi-Square Distribution | 1 | 2016 | 564 | 0.030 |
Why?
|
| Family | 1 | 2018 | 585 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2025 | 6450 | 0.030 |
Why?
|
| Coinfection | 1 | 2016 | 187 | 0.030 |
Why?
|
| Cause of Death | 1 | 2016 | 505 | 0.030 |
Why?
|
| Health Plan Implementation | 1 | 2013 | 40 | 0.030 |
Why?
|
| Contraindications | 1 | 2013 | 76 | 0.030 |
Why?
|
| Weaning | 1 | 2013 | 51 | 0.030 |
Why?
|
| Bottle Feeding | 1 | 2013 | 39 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2016 | 1076 | 0.020 |
Why?
|
| Postnatal Care | 1 | 2013 | 51 | 0.020 |
Why?
|
| Public Policy | 1 | 2013 | 54 | 0.020 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2017 | 427 | 0.020 |
Why?
|
| Child, Orphaned | 1 | 2013 | 21 | 0.020 |
Why?
|
| World Health Organization | 1 | 2013 | 115 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2016 | 1215 | 0.020 |
Why?
|
| Immunization Programs | 1 | 2013 | 68 | 0.020 |
Why?
|
| Lesotho | 1 | 2012 | 18 | 0.020 |
Why?
|
| HIV Seropositivity | 1 | 2013 | 125 | 0.020 |
Why?
|
| Child Nutritional Physiological Phenomena | 1 | 2013 | 157 | 0.020 |
Why?
|
| Vulnerable Populations | 1 | 2013 | 148 | 0.020 |
Why?
|
| Health Planning Guidelines | 1 | 2011 | 33 | 0.020 |
Why?
|
| Population Surveillance | 1 | 2013 | 397 | 0.020 |
Why?
|
| Social Support | 1 | 2013 | 362 | 0.020 |
Why?
|
| HIV Antibodies | 1 | 2011 | 69 | 0.020 |
Why?
|
| Health Promotion | 1 | 2013 | 411 | 0.020 |
Why?
|
| Evidence-Based Medicine | 1 | 2013 | 643 | 0.020 |
Why?
|
| Infant Mortality | 1 | 2011 | 181 | 0.020 |
Why?
|
| Age Factors | 1 | 2016 | 2838 | 0.020 |
Why?
|
| Electronic Health Records | 1 | 2016 | 817 | 0.020 |
Why?
|
| Global Health | 1 | 2013 | 634 | 0.020 |
Why?
|
| Pediatrics | 1 | 2018 | 1242 | 0.020 |
Why?
|
| Healthcare Disparities | 1 | 2013 | 508 | 0.020 |
Why?
|
| Feeding Behavior | 1 | 2013 | 711 | 0.020 |
Why?
|
| HIV-1 | 1 | 2011 | 484 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2013 | 1290 | 0.020 |
Why?
|
| Quality of Life | 1 | 2016 | 2082 | 0.020 |
Why?
|
| Middle Aged | 1 | 2025 | 28438 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2011 | 5081 | 0.010 |
Why?
|